首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

1377428

遺傳譜系市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按測試類型、按應用、最終用戶、地區和競爭細分

Genetic Genealogy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Test Type, By Application, By End User, By Region and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 171 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球基因譜系市場價值為 9.5939 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年複合CAGR為7.81%。基因譜系，也稱為遺傳血統測試，是一個深入研究研究家庭、他們的歷史以及追蹤他們的血統。它涉及研究和探索歷史內容的細緻過程，以挖掘迷人的細節並將其轉化為引人入勝的生活故事。這種深刻的探索讓我們深入了解我們的祖先——他們來自哪裡，他們如何生活，以及他們所堅持的文化傳統。

遺傳譜系學不僅讓我們能夠追根溯源、保存民族傳統，而且在解開我們的醫學歷史之謎和揭穿長期存在的家庭神話方面也發揮著至關重要的作用。透過彙編和出版家譜書籍，我們可以確保我們祖先的遺產得到珍惜並傳承給後代。家譜領域在世界各地廣泛流行，推動了家譜產品和服務的成長。此外，隨著各行業對基因和DNA檢測等醫學檢測的需求不斷增加，家譜市場正經歷強勁成長。隨著人們對家譜的認知不斷提高，越來越多的人正在尋求追溯他們的血統並揭開他們祖先的故事。這種趨勢在中國尤其明顯，中國很大一部分人口由於缺乏歷史記錄而面臨挑戰。

主要市場促進因素

市場概況
預測期	2024-2028
2022 年市場規模	95939萬美元
2028 年市場規模	148590萬美元
2023-2028 年CAGR	7.81%
成長最快的細分市場	遺傳與遺傳性疾病
最大的市場	北美洲

DNA 檢測需求激增

市場規模及預測
- 按價值
市佔率及預測
- 依測試類型（常染色體 DNA 測試、Y 染色體 DNA 測試、粒線體 DNA 測試）
- 按應用（遺傳和遺傳疾病、父系/母系血統、祖先起源、其他）
- 按最終用戶（直接面對消費者的測試公司、執法機構、研究機構和學術組織、其他）
- 按地區
- 按公司分類 (2022)
市場地圖

第 6 章：北美基因譜系市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按測試類型
- 按應用
- 按最終用戶
- 按國家/地區
北美：國家分析
- 美國
- 加拿大
- 墨西哥

第 7 章：歐洲遺傳譜系市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按測試類型
- 按應用
- 按最終用戶
- 按國家/地區
歐洲：國家分析
- 德國
- 英國
- 義大利
- 法國
- 西班牙

第 8 章：亞太遺傳譜系市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按測試類型
- 按應用
- 按最終用戶
- 按國家/地區
亞太地區：國家分析
- 中國
- 印度
- 日本
- 韓國
- 澳洲

第 9 章：南美洲遺傳譜系市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按測試類型
- 按應用
- 按最終用戶
- 按國家/地區
南美洲：國家分析
- 巴西
- 阿根廷
- 哥倫比亞

第 10 章：中東和非洲遺傳譜系市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按測試類型
- 按應用
- 按最終用戶
- 按國家/地區
MEA：國家分析
- 南非遺傳譜系
- 沙烏地阿拉伯遺傳譜系
- 阿拉伯聯合大公國遺傳譜系

第 11 章：市場動態

促進要素
挑戰

第 12 章：市場趨勢與發展

近期發展
併購
產品發布

第 13 章：全球基因譜系市場：SWOT 分析

第 14 章：波特的五力分析

產業競爭
新進入者的潛力
供應商的力量
客戶的力量
替代產品的威脅

第15章：競爭格局

商業概覽
服務內容
最近的發展
主要人員
SWOT分析
- 23&Me Inc.
- Ancestry.com
- MyHeritage
- Sequencing. Com
- FTDNA
- DNASolves
- Living DNA
- FindmyPast
- Familysearch
- Geneanet

第 16 章：策略建議

關於我們及免責聲明

簡介目錄

Product Code: 7693

Global Genetic Genealogy Market has valued at USD 959.39 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.81% through 2028. Genetic Genealogy, also known as genetic ancestry testing, is a captivating field that delves into the study of families, their history, and the tracing of their lineages. It involves a meticulous process of researching and exploring historical content to unearth fascinating details and transform them into engaging life stories. This profound exploration provides a deep understanding of our ancestors - where they came from, how they lived their lives, and the cultural traditions they upheld.

Not only does genetic genealogy allow us to connect with our roots and preserve ethnic traditions, but it also plays a vital role in unraveling the mysteries of our medical history and debunking long-standing family myths. By assembling and publishing family history books, we can ensure that the legacy of our ancestors is cherished and passed down to future generations. The field of genealogy has witnessed widespread popularity in different parts of the world, fueling the growth of genealogy products and services. Moreover, with the increasing demand for medical testing, such as genetic and DNA testing, across various industries, the genealogy market is experiencing strong growth. As awareness about genealogy continues to soar, more individuals are seeking to trace their lineages and uncover their ancestral stories. This trend is particularly evident in China, where a significant portion of the population faces challenges due to the lack of historical records.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 959.39 Million
Market Size 2028	USD 1485.90 Million
CAGR 2023-2028	7.81%
Fastest Growing Segment	Heredity & Genetic Disorders
Largest Market	North America

Surging Demand for DNA Testing

DNA carries essential genetic information for the growth, functioning, and reproduction of living organisms. DNA testing is conducted to detect any alterations in genetic material, aiding in the identification of various genetic risks associated with health conditions. This information enables individuals to make informed decisions about necessary lifestyle changes to achieve their health and wellness goals. Each person possesses a unique set of genetic variants, contributing to their individuality.

DNA testing plays a crucial role in solving criminal cases by establishing the presence of individuals at crime scenes. Forensic investigators collect samples such as blood, hair, or tissue from the crime scene, which are then analyzed in laboratories to verify the identity of the involved individuals. The results of DNA testing are generally accepted as factual evidence in court, providing a credible basis for judicial and law enforcement decisions.

Moreover, DNA testing aids in tracing and identifying ancestors, helping individuals discover lost relatives and understand their genetic heritage. It also assists in detecting life-threatening diseases like cancer and the presence of viruses in the body. Additionally, DNA testing can determine biological parentage and resolve legal cases. Furthermore, it provides detailed reports on genetic predispositions related to health, fitness, and nutrition, facilitating personalized lifestyle adjustments and health check-ups. The aforementioned factors contribute to the increasing demand for DNA testing, thereby driving the growth of the global genealogy products and services market.

High-End Investment for Research and Development Activities

Significant investments by leading authorities and organizations in research and development activities have paved the way for the remarkable growth of the genetic genealogy market. These investments are driven by the ever-increasing need to enhance our understanding of genetic ancestry and unlock the full potential of personalized medicine.

By leveraging advanced genetic testing and analysis techniques, genetic genealogy not only improves the quality of healthcare services provided to patients, but also opens up new possibilities for preventive care and targeted treatments. With the rising demand for high-quality healthcare services and the growing interest in personalized medicine, the genetic genealogy market is poised for lucrative opportunities and sustained growth.

The integration of genetic genealogy into healthcare systems has the potential to revolutionize patient care. By providing healthcare professionals with comprehensive genetic information, they can make more informed decisions about treatment plans, medication choices, and disease prevention strategies. This personalized approach to healthcare has the potential to greatly improve patient outcomes and overall quality of life.

Moreover, the advancements in genetic genealogy have also sparked interest among individuals seeking to delve into their own genetic heritage. People are now able to uncover fascinating insights about their ancestry, connecting with distant relatives, and exploring their family histories in ways that were previously unimaginable. This has created a burgeoning market for consumer genetic testing kits and services, further driving the growth of the genetic genealogy industry.

The genetic genealogy market is experiencing rapid expansion due to significant investments in research and development, the increasing need for genetic understanding, and the potential for personalized medicine. As the field continues to evolve, it holds tremendous promise for improving healthcare outcomes, enabling preventive care, and satisfying the curiosity of individuals eager to discover their genetic roots.

Ongoing Development of Pharmacogenomics

The field of pharmacogenomics, which is the study of how genetics influence the effects of medication on the human body, is experiencing continuous growth to meet the diverse and evolving needs of the global population. This rise can be attributed to the increasing awareness among consumers about the advantages of preventive healthcare and the potential of personalized medicine. By integrating genetic information into healthcare practices, there is a promising opportunity to revolutionize the way we approach treatment and improve patient outcomes on a larger scale.

As we delve deeper into the intricate relationship between genetics and medication response, the potential for tailored treatments based on an individual's genetic profile becomes increasingly apparent. This personalized approach has the potential to optimize drug efficacy, minimize adverse reactions, and ultimately enhance patient well-being. With advancements in technology and the availability of genetic testing, the demand for genetic genealogy services is expected to witness significant growth in the next five years.

By harnessing the power of pharmacogenomics, healthcare professionals can make more informed decisions about medication choices, dosages, and treatment plans. This precision medicine approach holds great promise in improving patient outcomes, reducing trial and error in treatment, and ultimately shaping the future of healthcare. Through the integration of genetic information and the continued advancement of pharmacogenomic research, we are poised to unlock a new era of personalized medicine that caters to the unique needs of each individual.

Increasing Demand of Personalized Treatment

By harnessing the power of genetic genealogy, healthcare facilities are empowered to deliver highly personalized treatment to their patients, aligning with the highest standards of quality in healthcare provision. This approach enables the development of effective products and services tailored specifically to the unique needs of each patient, ensuring optimal outcomes and improved overall healthcare experiences.

With major players in the industry embracing the study of genetic genealogy, such as leading research institutions and pharmaceutical companies investing in cutting-edge technologies, the future of personalized medicine looks promising. The integration of genetic insights into healthcare practices opens up new avenues for precise diagnostics, targeted therapies, and preventive interventions. Patients can benefit from early detection of genetic predispositions, personalized treatment plans, and improved disease management strategies.

In this new era of precision healthcare, medical professionals can utilize advanced genomic data analysis, bioinformatics, and artificial intelligence to identify genetic markers, predict disease risks, and optimize treatment approaches. This holistic approach not only enhances patient outcomes but also helps in reducing healthcare costs by avoiding unnecessary treatments and interventions.

As the field of genetic genealogy continues to evolve, the potential for innovation and advancements in personalized medicine is vast. From tailoring medications based on an individual's genetic makeup to developing gene therapies for previously untreatable conditions, the possibilities are endless. By integrating genetic information into routine healthcare practices, we can revolutionize the way diseases are diagnosed, managed, and treated. The integration of genetic genealogy into healthcare practices holds immense promise for the future of personalized medicine. With a focus on individualized care, precise diagnostics, and targeted therapies, we can usher in an era of improved patient outcomes and enhanced overall healthcare experiences.

Key Market Challenges

Misuse of Data

The rapidly growing field of genetic genealogy testing offers individuals unprecedented insights into their ancestry and familial connections, but it also raises concerns about the potential misuse of sensitive genetic data. These concerns have the potential to decrease the demand for genetic genealogy testing services if not adequately addressed. Customers worry that their genetic information could be accessed by malicious actors, insurance companies, or employers, leading to discrimination or other harmful consequences. To mitigate this risk, genetic testing companies must implement robust data protection measures, including encryption, secure storage, and stringent access controls. Additionally, stringent data-sharing agreements should be established to ensure that genetic information is not sold or shared without explicit consent.

Another issue is the ethical use of genetic data in law enforcement investigations. The misuse of genetic databases for criminal investigations without informed consent has led to controversy and erosion of trust. Stricter regulations and guidelines governing the use of genetic data in criminal cases can help restore confidence in the industry.

To further reduce the chances of misuse, companies should educate consumers about the risks and benefits of genetic testing and provide clear, user-friendly privacy policies. Offering anonymous testing options or allowing users to control the level of data sharing can also alleviate privacy concerns.

High Costs of Genetic Testing

The high costs associated with genetic testing have the potential to significantly decrease the demand for genetic genealogy testing services, limiting access to valuable insights about one's ancestry and genetic heritage.

The upfront expense of genetic testing can be a substantial barrier for many individuals. High testing fees can dissuade potential customers from seeking out these services, especially those with limited financial resources. This can result in a skewed representation of genetic data, as only those who can afford it may participate, leading to a potential underrepresentation of certain populations. To address this issue, genetic testing companies should explore pricing models that make these services more affordable or offer discounts to individuals with lower incomes.

Moreover, there may be hidden costs associated with genetic testing. Some individuals may need to consult with genetic counselors or healthcare professionals to interpret their results, incurring additional expenses. To alleviate this burden, genetic testing companies should provide comprehensive and user-friendly reports that are easy for individuals to understand without the need for costly expert consultations. Insurance coverage is another concern. Many insurance policies do not cover genetic testing, which can further increase the overall cost for individuals. Advocacy for insurance coverage and changes in policy could help reduce this financial burden and encourage more people to consider genetic genealogy testing.

Key Market Trends

Development in Pharmacogenomics

Pharmacogenomics aims to tailor drug treatments to an individual's genetic profile, optimizing the efficacy and safety of medications. As this field advances, genetic testing becomes increasingly essential for healthcare providers to make informed decisions about drug prescriptions. Genetic genealogy testing, which already provides a wealth of genetic data, can serve as a foundational resource for pharmacogenomic assessments. This synergy between genetic genealogy and pharmacogenomics can drive greater interest and demand for genetic testing services.

Moreover, as pharmacogenomics evolves, individuals may be more inclined to undergo genetic testing to gain insights not only into their ancestry and familial connections but also into their genetic predispositions for drug responses. This dual benefit of genetic testing-both for ancestry exploration and personalized medicine-can make the investment in genetic testing more appealing to a broader audience. The integration of pharmacogenomics into routine healthcare can also lead to partnerships between genetic testing companies and healthcare providers. This collaboration could streamline the testing process and increase access to genetic information, further boosting demand.

Additionally, as more drugs are developed with a personalized approach in mind, pharmaceutical companies may encourage genetic testing to identify potential patient populations that would benefit most from their products. This could lead to incentives for individuals to undergo genetic testing.

Increasing Use for Family Tree Information

The increasing use of family tree information and the growing popularity of genealogical research can significantly boost the demand for genetic genealogy testing in the future. Genetic genealogy testing provides a scientific dimension to traditional genealogy research. It can confirm existing family tree information, resolve long-standing genealogical mysteries, and uncover previously unknown branches of the family tree. As genealogists and enthusiasts discover the value of DNA testing in complementing their research, the demand for genetic genealogy testing is likely to rise.

Genetic genealogy tests not only help individuals understand their ancestral origins but also connect them with living relatives. The prospect of discovering unknown cousins or distant family members can be a powerful motivator for people to undergo genetic testing. The more individuals realize the potential for these connections, the greater the demand for testing services. Many people are increasingly interested in exploring their cultural and heritage backgrounds. Genetic genealogy testing can provide insights into one's ethnic makeup, helping individuals better understand their roots and cultural heritage. This added layer of identity and connection can be a compelling reason to pursue genetic genealogy testing. Genetic genealogy testing has educational and recreational value. It can turn genealogy into a fascinating hobby and provide an educational experience for families, schools, and community groups. As more people become interested in these aspects, the demand for genetic genealogy testing kits for both personal and educational purposes is likely to increase.

Segmental Insights

Test Type Insights

Based on the test type, autosomal DNA testing dominates the market in 2022 due to its origin in the nucleus, representing an equal contribution of genetic material from both parents to their offspring. Each individual inherits 50% of their nuclear DNA from their father and 50% from their mother. This pattern continues through each generation, resulting in approximately 25% of DNA from each grandparent, 12.5% from each great-grandparent, and so on. Autosomal DNA testing is crucial for accurately estimating a family tree, as every individual carries a certain amount of equal autosomal DNA.

In contrast, Y-chromosome DNA testing focuses on the paternal line. The Y-chromosome is passed virtually unchanged from father to son, meaning that an individual shares the same Y-DNA as their father, grandfather, and great-grandfather, as well as their paternal uncle and grandfather's brothers. While this type of testing is valuable for studying family names in patrilineal societies, it does not provide information about which specific brother an individual descended from, as all males within the family share the same Y-DNA.

End User Insights

Based on the end user segment, Direct-to-consumer (DTC) genetic testing companies have rapidly dominated the genetic genealogy testing market for several compelling reasons. First and foremost, they offer unparalleled convenience. With DTC testing, individuals can order a DNA testing kit online or purchase one from a retail store, collect their DNA samples at home, and send them back for analysis. This streamlined process eliminates the need for healthcare professionals or intermediaries, making it accessible to a wide range of consumers.

Additionally, DTC testing companies have capitalized on the growing interest in ancestry exploration and personalized genetics. They provide comprehensive reports that not only reveal ancestral origins but also connect individuals with potential relatives in their databases, tapping into the emotional appeal of discovering long-lost family connections. Moreover, the competitive pricing of DTC genetic tests has democratized access to genetic information, making it affordable for a broader audience. The ease of online marketing and advertising has allowed these companies to reach a global customer base, further expanding their market dominance.

Regional Insights

The North America region is projected to dominate the market during the forecast period of 2024-2028. This can be attributed to the presence of key market players in the region, coupled with a well-developed healthcare infrastructure, which serves as the primary driver behind the substantial growth of the genetic genealogy market. Furthermore, robust economic growth and significant investments by major players have led to a notable upsurge in market expansion. Additionally, heightened consumer awareness regarding the advantages of quality treatment, combined with favorable reimbursement policies for healthcare services, has contributed to the upward trajectory of market growth.

Key Market Players

23&Me Inc.

Ancestry.com

MyHeritage

Sequencing. Com

FTDNA

DNASolves

Living DNA

FindmyPast

Familysearch

Geneanet

Report Scope:

In this report, the Global Genetic Genealogy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genetic Genealogy Market, By Test Type:

Autosomal DNA Test
Y- chromosome DNA Test
Mitochondrial DNA Test

Genetic Genealogy Market, By Application:

Heredity & Genetic Disorders
Paternal/Maternal Lineages
Ancestral Origins
Others

Genetic Genealogy Market, By End User:

Direct-to-Consumer Testing Companies
Law Enforcement Agencies
Research Institutes & Academic Organizations
Others

Genetic Genealogy Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genetic Genealogy Market.

Available Customizations:

Global Genetic Genealogy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genetic Genealogy Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (Autosomal DNA Test, Y- chromosome DNA Test, Mitochondrial DNA Test)
- 5.2.2. By Application (Heredity & Genetic Disorders, Paternal/Maternal Lineages, Ancestral Origins, Others)
- 5.2.3. By End User (Direct-to-Consumer Testing Companies, Law Enforcement Agencies, Research Institutes & Academic Organizations, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
5.3. Market Map

6. North America Genetic Genealogy Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Application
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Genetic Genealogy Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Test Type
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Genetic Genealogy Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Test Type
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Genetic Genealogy Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Test Type
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End User

7. Europe Genetic Genealogy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Genetic Genealogy Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Test Type
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End User
- 7.3.2. United Kingdom Genetic Genealogy Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Test Type
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End User
- 7.3.3. Italy Genetic Genealogy Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Test Type
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End User
- 7.3.4. France Genetic Genealogy Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Test Type
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Genetic Genealogy Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Test Type
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End User

8. Asia-Pacific Genetic Genealogy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Genetic Genealogy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Test Type
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End User
- 8.3.2. India Genetic Genealogy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Test Type
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Genetic Genealogy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Test Type
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Genetic Genealogy Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Test Type
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Genetic Genealogy Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Test Type
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End User

9. South America Genetic Genealogy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Genetic Genealogy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Test Type
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End User
- 9.3.2. Argentina Genetic Genealogy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Test Type
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End User
- 9.3.3. Colombia Genetic Genealogy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Test Type
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End User

10. Middle East and Africa Genetic Genealogy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Genetic Genealogy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Test Type
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End User
- 10.3.2. Saudi Arabia Genetic Genealogy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Test Type
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End User
- 10.3.3. UAE Genetic Genealogy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Test Type
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Genetic Genealogy Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. 23&Me Inc.
- 15.5.2. Ancestry.com
- 15.5.3. MyHeritage
- 15.5.4. Sequencing. Com
- 15.5.5. FTDNA
- 15.5.6. DNASolves
- 15.5.7. Living DNA
- 15.5.8. FindmyPast
- 15.5.9. Familysearch
- 15.5.10. Geneanet